Vitamin D supplementation and antibodies against the Epstein-Barr virus in multiple sclerosis patients

This publication has 12 references indexed in Scilit:

• Epstein-Barr virus antibodies and vitamin D in prospective multiple sclerosis biobank samples
  Multiple Sclerosis Journal, 2013
• Vitamin D as a protective factor in multiple sclerosis
  Neurology, 2012
• Effect of vitamin D₃ supplementation on peripheral B cell differentiation and isotype switching in patients with multiple sclerosis
  Multiple Sclerosis Journal, 2011
• Vitamin D and the anti-viral state
  Journal of Clinical Virology, 2011
• Antibacterial effects of vitamin D
  Nature Reviews Endocrinology, 2011
• Safety and T Cell Modulating Effects of High Dose Vitamin D3 Supplementation in Multiple Sclerosis
  PLOS ONE, 2010
• Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI
  Neurology, 2009
• Modulatory Effects of 1,25-Dihydroxyvitamin D3 on Human B Cell Differentiation
  The Journal of Immunology, 2007
• Serum 25-Hydroxyvitamin D Levels and Risk of Multiple Sclerosis
  JAMA, 2006
• Temporal Relationship Between Elevation of Epstein-Barr Virus Antibody Titers and Initial Onset of Neurological Symptoms in Multiple Sclerosis
  JAMA, 2005